tiprankstipranks
Avalo Therapeutics (AVTX)
NASDAQ:AVTX
AVTX
Avalo Therapeutics
RESEARCH TOOLSreports

Avalo Therapeutics (AVTX) Revenue

1,049 Followers
StatisticsMarket CapRevenue

Avalo Therapeutics Revenue

Avalo Therapeutics had a revenue of 59.00K in the quarter ending Dec 31, 2025, with Infinity%. This bring the company's revenue in the last twelve months to 59.00K, Increased -69.27%. In the fiscal year ending Dec 31, 2025, Avalo Therapeutics had annual revenue of 59.00K with -86.62% growth.
Revenue (ttm)
59.00K
Revenue Growth
-76.59%
P/S Ratio
5565.79
Revenue/Employee
$2,565
Employees
23
Market Cap
$328.38M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
59.00K-382.00K-86.62%
Dec 31, 2024
441.00K-1.48M-77.08%
Dec 31, 2023
1.92M-16.13M-89.34%
Dec 31, 2022
18.05M12.65M+234.40%
Dec 31, 2021
5.40M-1.30M-19.42%
Dec 31, 2020
6.70M-51.35K-0.76%
Dec 31, 2019
6.75M-11.58M-63.17%
Dec 31, 2018
18.33M-9.49M-34.11%
Dec 31, 2017
27.81M――